Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05907304
Title A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations (SEACRAFT-1)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Erasca, Inc.
Age Groups: child | adult | senior
Covered Countries USA

Additional content available in CKB BOOST